Announced
Completed
RA Capital completed the $15m investment in Medicenna Therapeutics.
Synopsis
RA Capital, an American investment firm, completed the $15m investment in Medicenna Therapeutics, a clinical stage immunotherapy company.
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
All rights reserved. Copyright © 2025 Datasite